Journal of Obesity / 2017 / Article / Tab 4 / Research Article
Web-Based Interventions Alone or Supplemented with Peer-Led Support or Professional Email Counseling for Weight Loss and Weight Maintenance in Women from Rural Communities: Results of a Clinical Trial Table 4 Observed means of primary outcome measures of intervention groups.
Variable Web-based only (WO) Web-based discussion (WD) Web-based email (WE) Mean (SD) Mean (SD) Mean (SD) Body weight (kg) Baseline 101 93.6 (13.7) 100 94.5 (12.9) 100 93.3 (12.6) 6 months 87 88.0 (14.6) 88 89.4 (13.9) 92 87.2 (13.5) 18 months 81 88.9 (14.8) 72 89.6 (13.6) 77 88.3 (15.5) 30 months 76 89.4 (14.0) 67 90.4 (13.3) 73 89.5 (16.7) Waist circumference (cm) Baseline 101 109.4 (11.6) 100 108.8 (10.9) 100 108.5 (10.0) 6 months 87 102.8 (12.1) 88 103.3 (11.6) 91 102.4 (11.2) 18 months 81 104.4 (12.0) 71 104.1 (11.3) 75 103.8 (13.4) 30 months 76 103.8 (12.0) 66 103.8 (10.6) 73 104.3 (13.6) Kcal intake daily Baseline 101 1809 (729) 100 1930 (675) 100 1789 (556) 6 months 85 1516 (535) 88 1514 (513) 91 1415 (447) 18 months 79 1532 (587) 70 1527 (610) 73 1371 (534) 30 months 75 1473 (499) 65 1384 (434) 72 1375 (511) Weekly minutes ≥ moderate intensity activity (Actigraph) Baseline 100 274.6 (149.6) 99 252.0 (125.0) 100 227.2 (137.3) 6 months 86 299.1 (165.3) 84 273.0 (154.5) 87 239.2 (126.0) 18 months 78 260.3 (133.5) 71 251.8 (137.7) 72 219.6 (113.3) 30 months 72 267.3 (133.1) 65 248.4 (150.6) 68 231.5 (131.0) Weekly minutes ≥ moderate intensity activity (BRFSS) Baseline 101 127.8 (197.9) 100 104.4 (135.6) 100 109.7 (139.6) 6 months 87 183.9 (232.1) 88 133.4 (172.5) 91 171.2 (274.7) 18 months 81 123.6 (146.5) 71 125.1 (188.4) 75 125.9 (186.2) 30 months 76 119.4 (160.8) 66 108.0 (171.2) 73 100.4 (131.1 Systolic blood pressure (mmHg) Baseline 101 123.4 (12.6) 100 121.4 (10.9) 100 124.4 (12.3) 6 months 87 120.5 (16.3) 88 120.1 (12.5) 91 120.6 (13.0) 18 months 81 122.0 (17.0) 71 120.1 (11.6) 75 121.3 (13.2) 30 months 76 122.0 (13.0) 66 120.7 (13.3) 73 122.0 (14.7) Diastolic blood pressure (mmHg) Baseline 101 76.9 (7.9) 100 76.5 (7.8) 100 77.0 (8.2) 6 months 87 75.8 (8.7) 88 75.6 (9.0) 91 75.6 (8.4) 18 months 81 76.0 (9.1) 71 75.6 (7.8) 75 74.8 (9.6) 30 months 76 75.7 (7.7) 66 74.8 (8.4) 73 74.7 (8.8) Total cholesterol (mL/dL) Baseline 100 196.8 (36.8) 99 200.4 (37.4) 100 200.4 (43.7) 6 months 86 199.6 (41.8) 88 204.7 (36.9) 92 192.0 (45.1) 18 months 81 200.0 (32.7) 72 211.7 (35.0) 74 198.7 (39.9) 30 months 73 201.7 (33.5) 66 210.5 (35.8) 71 196.6 (40.8) HDL (mL/dL) Baseline 101 48.5 (10.6) 99 50.5 (13.2) 100 49.8 (14.6) 6 months 86 53.0 (11.7) 88 53.7 (11.3) 92 50.0 (13.0) 18 months 81 56.1 (12.5) 72 56.6 (11.3) 74 54.6 (11.0) 30 months 73 56.1 (10.8) 66 58.5 (14.8) 71 54.1 (12.0) LDL (mL/dL) Baseline 101 121.7 (32.4) 98 124.8 (32.5) 100 122.2 (35.3) 6 months 86 122.8 (34.4) 88 127.7 (32.4) 92 116.9 (37.0) 18 months 80 117.5 (30.0) 71 129.2 (29.6) 74 119.5 (36.5) 30 months 73 119.3 (29.9) 64 126.3 (29.7) 71 116.0 (35.1) Triglycerides (mL/dL) Baseline 101 134.7 (68.6) 99 129.6 (87.5) 100 141.6 (69.2) 6 months 86 118.8 (60.3) 88 116.7 (53.9) 92 125.6 (63.0) 18 months 81 136.0 (76.4) 72 129.4 (75.1) 74 122.9 (55.4) 30 months 73 131.8 (63.9) 66 128.9 (72.7) 71 132.7 (60.2) Fasting glucose (mL/dL) Baseline 101 101.7 (15.5) 99 102.0 (22.2) 100 99.4 (14.2) 6 months 86 87.7 (14.5) 88 100.9 (21.4) 92 99.0 (15.8) 18 months 81 97.7 (11.5) 72 96.3 (12.2) 74 97.7 (14.2) 30 months 73 99.6 (12.2) 66 100.5 (19.9) 70 97.7 (16.5)
Note: 6, 18, and 30 months corresponded to the end of phases 1, 2, and 3, respectively.